Voice of Cannabis Series - Episode 1 | SALT Talks #49 | Summary and Q&A

TL;DR

The CBD industry in the United States is facing challenges due to regulatory ambiguity, particularly from the FDA. However, there is optimism for future regulation and the industry is focused on providing high-quality products and collaborating with regulatory bodies.

Key Insights

• 😋 The FDA's lack of regulation for CBD in dietary supplements and foods has created uncertainty in the industry, affecting farmers and businesses.
• 🥘 There is movement on Capitol Hill to regulate CBD or amend existing laws to allow its use in dietary supplements and foods.
• 🥡 State regulations vary, with some states taking a proactive approach and others being more hesitant.
• ✋ The CBD industry is collaborating with regulatory bodies, providing data and striving to maintain high standards to address concerns and build consumer trust.
• 🪡 The passage of the Agriculture Improvement Act in 2018 legalized hemp and its derivatives, but further regulation is needed for CBD products.
• 💁 The future of the CBD industry is promising, with potential for various product form factors and increased regulation to ensure consumer safety and product quality.
• 💱 The upcoming election may have implications for the CBD industry, with the potential for regulatory changes depending on the outcome.
• ❓ Collaboration between industry stakeholders and regulatory bodies is essential for the development and regulation of the CBD market.

Transcript

hello everyone welcome back to salt talks my name is joe aletto and i'm the production manager of salt which is a global thought leadership forum and networking platform encompassing finance technology and geopolitics fall talks is a series of digital interviews with the world's foremost investors creators and thinkers and just as we do at our glob... Read More

Questions & Answers

Q: How is the FDA currently regulating CBD products in the US?

The FDA has not yet regulated CBD in dietary supplements and foods. They have expressed concerns about safety and are evaluating the impacts of CBD consumption. Stakeholders are providing data to address these concerns.

Q: Is there movement on Capitol Hill to regulate CBD?

Yes, there is pressure from both sides of the aisle to regulate CBD or amend existing laws to allow its use in dietary supplements and foods. Congressional leaders and senators have proposed legislation to address this issue.

Q: How are states regulating the production and sale of CBD products?

State regulations vary, with some states like New York and California taking a proactive approach in regulating CBD products. Others are more reluctant and uncertain about how to handle issues such as THC levels and product types.

Q: How is the CBD industry working with regulatory bodies to address concerns?

Companies like Canopy Growth are collaborating with regulatory bodies like the FDA to provide data and address safety concerns. They are focusing on maintaining high standards and providing high-quality products to build trust with consumers and regulators.

Summary & Key Takeaways

• The passage of the Agriculture Improvement Act in 2018 legalized hemp and its derivatives, including CBD. However, the FDA has not yet regulated CBD in dietary supplements and foods, causing uncertainty in the industry.

• The FDA has expressed concerns about the safety of CBD and is currently evaluating its impact on human consumption. Stakeholders, including companies like Canopy Growth, are providing data to address these concerns.

• There is movement on Capitol Hill to regulate CBD or amend existing laws to allow its use in dietary supplements and foods. The industry is hopeful for progress in terms of regulation in the near future.

• State-level regulations vary, with some states like New York and California taking a proactive approach in regulating CBD products. Others are more reluctant and uncertain about how to handle issues such as THC levels and product types.